Reference Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway.
Antimicrob Agents Chemother. 2010 Jan;54(1):346-52. doi: 10.1128/AAC.00824-09. Epub 2009 Nov 2.
Scandinavia is considered a region with a low prevalence of antimicrobial resistance. However, the number of multidrug-resistant (MDR) Gram-negative bacteria is increasing, including metallo-beta-lactamase (MBL)-producing Pseudomonas aeruginosa. In this study MBL-producing P. aeruginosa isolates identified in Norway (n = 4) and Sweden (n = 9) from 1999 to 2007 were characterized. Two international clonal complexes (CC), CC111 (n = 8) and CC235 (n = 2), previously associated with MBL-producing isolates, were dominant. CC111 isolates (ST111/229; serotype O12; bla(VIM-2)) included clonally related isolates identified in Skåne County, Sweden (n = 6), and two isolates associated with importation from Greece and Denmark. In all CC111 isolates, bla(VIM-2) was located in integron In59.2 or In59 variants. The two CC235 isolates (ST235/ST230; serotype O11; bla(VIM-4)) were imported from Greece and Cyprus, were possibly clonally related, and carried bla(VIM-4) in two different integron structures. Three isolates imported from Ghana (ST233; serotype O6; bla(VIM-2)), Tunisia (ST654; serotype O11; bla(VIM-2)), and Thailand (ST260; serotype O6; bla(IMP-14)) were clonally unrelated. ST233 was part of a new CC (CC233) that included other MBL-producing isolates, while ST654 could also be part of a new CC associated with MBL producers. In the isolates imported from Ghana and Tunisia, bla(VIM-2) was part of unusual integron structures lacking the 3' conserved segment and associated with transposons. The bla(VIM) gene was found to be located on the chromosome in all isolates. Known risk factors for acquisition of MBL were reported for all patients except one. The findings suggest that both import of successful international clones and local clonal expansion contribute to the emergence of MBL-producing P. aeruginosa in Scandinavia.
斯堪的纳维亚被认为是一个抗生素耐药率较低的地区。然而,耐多药(MDR)革兰氏阴性菌的数量正在增加,包括产金属β-内酰胺酶(MBL)的铜绿假单胞菌。在这项研究中,从 1999 年到 2007 年,在挪威(n=4)和瑞典(n=9)鉴定出的产 MBL 铜绿假单胞菌分离株进行了特征描述。两个国际克隆复合体(CC),CC111(n=8)和 CC235(n=2),以前与产 MBL 分离株有关,占主导地位。CC111 分离株(ST111/229;血清型 O12;bla(VIM-2))包括在瑞典斯科讷县(n=6)鉴定的克隆相关分离株,以及与从希腊和丹麦进口有关的两个分离株。在所有 CC111 分离株中,bla(VIM-2)位于整合子 In59.2 或 In59 变体中。两个 CC235 分离株(ST235/ST230;血清型 O11;bla(VIM-4))从希腊和塞浦路斯进口,可能具有克隆相关性,并且在两个不同的整合子结构中携带 bla(VIM-4)。从加纳(ST233;血清型 O6;bla(VIM-2))、突尼斯(ST654;血清型 O11;bla(VIM-2))和泰国(ST260;血清型 O6;bla(IMP-14))进口的三个分离株无相关性。ST233 是一个新 CC(CC233)的一部分,该 CC 包括其他产 MBL 分离株,而 ST654 也可能是与产 MBL 分离株相关的新 CC 的一部分。在从加纳和突尼斯进口的分离株中,bla(VIM-2)是缺乏 3'保守片段的不寻常整合子结构的一部分,与转座子有关。bla(VIM)基因被发现位于所有分离株的染色体上。除了一个病人外,所有病人都报告了获得 MBL 的已知危险因素。研究结果表明,成功的国际克隆的输入和本地克隆的扩张都有助于 MBL 产铜绿假单胞菌在斯堪的纳维亚的出现。